Global Genetic Testing Market By End User
Healthcare & Pharma
Global Genetic Testing Market By Application
By Application, the market is segmented into Cervical Cancer, Colorectal Cancer, Liver Cancer, Lymphoma, Oral Cancer, Others, and Stomach (Gastric) Cancer (2019–2035)
Author: Wantstats Research TeamSource: Wantstats Repository
| Label | Cervical Cancer | Colorectal Cancer | Liver Cancer | Lymphoma | Oral Cancer | Others | Stomach (Gastric) Cancer |
|---|---|---|---|---|---|---|---|
| 2019 | 52.8507 | 100.4874 | 28.284 | 19.1935 | 27.7513 | 162.7591 | 33.9402 |
| 2020 | 48.2633 | 91.185 | 27.5522 | 17.6958 | 24.9862 | 145.6748 | 31.6148 |
| 2021 | 50.2553 | 94.3488 | 30.4705 | 18.6001 | 25.6492 | 148.6313 | 33.5611 |
| 2022 | 52.5842 | 98.0983 | 33.7324 | 19.6427 | 26.4553 | 152.3452 | 35.7826 |
| 2023 | 55.1549 | 102.2458 | 37.3076 | 20.791 | 27.3505 | 156.4885 | 38.2256 |
| 2024 | 58.1291 | 107.077 | 42.1047 | 22.1354 | 28.4404 | 160.4502 | 41.1568 |
| 2025 | 62.6364 | 114.6562 | 47.0869 | 24.0468 | 30.1811 | 169.7766 | 45.0407 |
| 2026 | 67.8141 | 123.3562 | 52.9091 | 26.2474 | 32.1809 | 180.3491 | 49.5255 |
| 2027 | 74.0816 | 133.9127 | 59.9868 | 28.9076 | 34.6226 | 193.1345 | 54.9475 |
| 2028 | 81.7827 | 146.9075 | 68.7291 | 32.1734 | 37.6431 | 208.8105 | 61.6065 |
| 2029 | 91.1065 | 162.6314 | 79.4625 | 36.1343 | 41.3001 | 227.5817 | 69.7013 |
| 2030 | 102.2836 | 181.4404 | 92.5871 | 40.8986 | 45.6654 | 249.6968 | 79.4735 |
| 2031 | 115.6585 | 203.8823 | 108.6559 | 46.6243 | 50.8559 | 275.606 | 91.268 |
| 2032 | 132.1275 | 231.457 | 128.8247 | 53.6982 | 57.2193 | 306.9392 | 105.8906 |
| 2033 | 152.0095 | 264.6207 | 153.8175 | 62.2827 | 64.8348 | 343.7755 | 123.7248 |
| 2034 | 176.8011 | 305.8543 | 185.6727 | 73.0317 | 74.2699 | 388.6685 | 146.1476 |
| 2035 | 208.5637 | 358.547 | 227.3155 | 86.855 | 86.29 | 444.9484 | 175.0916 |
Data Source: Wantstats Repository
Growth Outlook
- The Global Genetic Testing Market By Application market is on a steady long-term growth path. Segment value stands at roughly USD 532 Million in 2026 and is projected to reach USD 1588 Million by 2035 — a gain of about 198% over the forecast period, translating to a CAGR in the double digits.
- What the regional split looks like (2026): Others leads, holding roughly 34% of segment value — the single largest regional share. Colorectal Cancer is the second-largest contributor. Cervical Cancer, Liver Cancer, Stomach (Gastric) Cancer, Oral Cancer and Lymphoma make up the remainder, in descending order.
- By 2035, Others alone is expected to reach USD 445 Million, with Colorectal Cancer at USD 359 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
USD49
Buy NowPowering the world's best teams.
From next-gen startups to established enterprises.
Contact us
Get in Touch
Let's work together
support@wantstats.comWantstats Research and Media Pvt. Ltd., Office No 104, Pentagon 4, Magarpatta City, Pune - 411028, Maharashtra, India.
See our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Global Genetic Testing Market By Application
One-time
$49



